Syed, Muslim Abbas http://orcid.org/0000-0003-4372-1935
Aiyegbusi, Olalekan Lee http://orcid.org/0000-0001-9122-8251
Marston, Eliot
Lord, Janet M. http://orcid.org/0000-0003-1030-6786
Teare, Harriet
Calvert, Melanie http://orcid.org/0000-0002-1856-837X
Article History
Received: 7 November 2022
Accepted: 9 November 2022
First Online: 17 November 2022
Declarations
:
: MC is Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation, Director of the Centre for the Centre for Patient Reported Outcomes Research and is a National Institute for Health and Care Research (NIHR) Senior Investigator. MC receives funding from the NIHR Birmingham Biomedical Research Centre, NIHR Surgical Reconstruction and Microbiology Research Centre (SRMRC), NIHR Birmingham-Oxford Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, and NIHR ARC West Midlands at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Health Data Research UK, Innovate UK (part of UK Research and Innovation), Macmillan Cancer Support, UK SPINE, UKRI, UCB Pharma, GSK and Gilead. MC has received personal fees from Astellas, Aparito Ltd, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute (PCORI) outside the submitted work.OLA receives funding from the NIHR Birmingham Biomedical Research Centre (BRC), NIHR Applied Research Collaboration (ARC), West Midlands, NIHR Birmingham-Oxford Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics at the University of Birmingham and University Hospitals Birmingham NHS Foundation, Innovate UK (part of UK Research and Innovation), Health Foundation, Gilead Sciences Ltd, Merck, and Sarcoma UK. OLA declares personal fees from Gilead Sciences Ltd, GlaxoSmithKline (GSK) and Merck outside the submitted work.JML is Director of the MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research and receives funding from the NIHR Birmingham Biomedical Research Centre, NIHR SRMRC, Scar Free Foundation, UK SPINE, FOREUM, UKRI and Bayer Healthcare. JML has acted as a consultant to Bayer Healthcare.The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The study sponsor and funder had no roles in study design, analysis and interpretation of data; writing of the report and the decision to submit the report for publication.